ATE181485T1 - Mit enantiomeren angereichertes, energiereiches nahrungsmittel - Google Patents
Mit enantiomeren angereichertes, energiereiches nahrungsmittelInfo
- Publication number
- ATE181485T1 ATE181485T1 AT96200875T AT96200875T ATE181485T1 AT E181485 T1 ATE181485 T1 AT E181485T1 AT 96200875 T AT96200875 T AT 96200875T AT 96200875 T AT96200875 T AT 96200875T AT E181485 T1 ATE181485 T1 AT E181485T1
- Authority
- AT
- Austria
- Prior art keywords
- chiral
- monoisomeric
- alkanoates
- enteral
- acid esters
- Prior art date
Links
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical compound C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 208000002720 Malnutrition Diseases 0.000 abstract 1
- -1 alpha, beta-D-glucopyranosyl Chemical group 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 230000001071 malnutrition Effects 0.000 abstract 1
- 235000000824 malnutrition Nutrition 0.000 abstract 1
- 208000030159 metabolic disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 208000015380 nutritional deficiency disease Diseases 0.000 abstract 1
- 235000016236 parenteral nutrition Nutrition 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
- 230000008733 trauma Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
- A23D9/013—Other fatty acid esters, e.g. phosphatides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Food Science & Technology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/417,943 US6306828B1 (en) | 1995-04-06 | 1995-04-06 | Enantiomerically-enhanced nutritional energy substrates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE181485T1 true ATE181485T1 (de) | 1999-07-15 |
Family
ID=23655996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96200875T ATE181485T1 (de) | 1995-04-06 | 1996-04-03 | Mit enantiomeren angereichertes, energiereiches nahrungsmittel |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6306828B1 (de) |
| EP (1) | EP0736256B1 (de) |
| JP (1) | JPH08283163A (de) |
| AT (1) | ATE181485T1 (de) |
| AU (1) | AU707531B2 (de) |
| CA (1) | CA2173270A1 (de) |
| DE (1) | DE69602985T2 (de) |
| DK (1) | DK0736256T3 (de) |
| ES (1) | ES2138284T3 (de) |
| GR (1) | GR3031086T3 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6482853B1 (en) * | 2000-07-12 | 2002-11-19 | George A. Brooks | Lactate thiolester for cardiac energy resuscitation and prevention of reperfusion injury and use as an energy supplement during exercise and recovery |
| NZ543201A (en) * | 2003-05-01 | 2007-05-31 | Innogene Kalbiotech Pte Ltd | Lactate containing pharmaceutical composition and uses thereof |
| AU2004245567B2 (en) | 2003-06-03 | 2011-06-23 | Oxford University Innovation Limited | Nutritional supplements and therapeutic compositions comprising (R)-3-hydroxybutyrate derivatives |
| EP2240017B1 (de) | 2008-01-04 | 2019-03-13 | Oxford University Innovation Limited | Ketonkörper und ketonkörperester als blutfettsenkende mittel |
| US8642654B2 (en) | 2009-04-16 | 2014-02-04 | Isis Innovation Limited | Hydroxybutyrate ester and medical use thereof |
| GB201002983D0 (en) | 2010-02-22 | 2010-04-07 | Tdeltas Ltd | Nutritinal composition |
| JP6883384B2 (ja) | 2012-11-05 | 2021-06-09 | ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 電離放射線による傷害から組織を防護するためのケトン体 |
| GB201304467D0 (en) | 2013-03-12 | 2013-04-24 | Tdeltas Ltd | Compound for use in protecting skin |
| SG11201507685UA (en) | 2013-03-14 | 2015-10-29 | Isis Innovation | Process for producing (r)-3-hydroxybutyl (r)-3-hydroxybutyrate |
| EP3043788B1 (de) * | 2013-09-13 | 2023-06-07 | Replicon Health OY | D-glycerinsäure oder dl-glycerinsäure zur verwendung bei der behandlung von altersbedingten degenerationskrankheiten |
| JP7235873B2 (ja) | 2019-01-17 | 2023-03-08 | アイオーアイ オレオ ゲーエムベーハー | ヒドロキシカルボン酸のグリセリドの製造方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5195121A (en) * | 1975-02-19 | 1976-08-20 | Urogasutoronno shokakankyushuseizodaiho | |
| JPS5334713A (en) | 1976-09-09 | 1978-03-31 | Nishikawa Yoshi | Method of manufacturing 11lauroyll glucopyranose |
| JPS5334712A (en) | 1976-09-09 | 1978-03-31 | Nishikawa Yoshi | Method of manufacturing 11stearoyll glucopyranose |
| US4107425A (en) * | 1977-02-15 | 1978-08-15 | The United States Of America As Represented By The Secretary Of Agriculture | Preparation of 1-α- and 1-β-glucose esters by stereoselective acylation of metalated 2,3,4,6,-tetra-O-benzyl-D-glucopyranose |
| US4675177A (en) * | 1980-10-09 | 1987-06-23 | American Cyanamid Company | Antiperspirant compositions |
| US4665057A (en) | 1983-03-22 | 1987-05-12 | Deanna Nelson | Nutrient monoesters |
| US4701443A (en) | 1983-03-22 | 1987-10-20 | Baxter Travenol Laboratories, Inc. | Nutrient polyesters |
| US4753963A (en) * | 1985-09-26 | 1988-06-28 | The Procter & Gamble Company | Nutritional fat suitable for enteral and parenteral products |
| JPH0667833B2 (ja) * | 1985-11-28 | 1994-08-31 | 雪印乳業株式会社 | 経腸栄養剤 |
| GB8620896D0 (en) * | 1986-08-29 | 1986-10-08 | Unilever Plc | Cosmetic composition |
| GB8809421D0 (en) * | 1988-04-21 | 1988-05-25 | Fordonal Sa | Antacid compositions with prolonged gastric residence time |
| JPH0651692B2 (ja) * | 1989-06-01 | 1994-07-06 | ダイソー株式会社 | 光学活性化合物 |
| JPH0383950A (ja) * | 1989-08-28 | 1991-04-09 | Kanegafuchi Chem Ind Co Ltd | グリセリド誘導体およびその製造法 |
| EP0465689B1 (de) | 1990-07-09 | 1994-02-02 | Societe Des Produits Nestle S.A. | Kalorienarme Nahrungsmittelzusammenstellung |
| US5256697A (en) | 1992-04-16 | 1993-10-26 | Abbott Laboratories | Method of administering pyruvate and methods of synthesizing pyruvate precursors |
| US5308832A (en) | 1992-07-27 | 1994-05-03 | Abbott Laboratories | Nutritional product for persons having a neurological injury |
| US5263260A (en) | 1992-08-03 | 1993-11-23 | Smith Lee R | Tile leveler and method |
| ATE175444T1 (de) * | 1992-10-29 | 1999-01-15 | Loders Croklaan Bv | Enzymatisches triglycerid-umsetzverfahren |
| WO1995009144A1 (en) * | 1993-09-30 | 1995-04-06 | Eastman Chemical Company | Nutritive water soluble glycerol esters of hydroxy butyric acid |
-
1995
- 1995-04-06 US US08/417,943 patent/US6306828B1/en not_active Expired - Fee Related
-
1996
- 1996-04-02 CA CA002173270A patent/CA2173270A1/en not_active Abandoned
- 1996-04-02 AU AU50456/96A patent/AU707531B2/en not_active Ceased
- 1996-04-03 EP EP96200875A patent/EP0736256B1/de not_active Expired - Lifetime
- 1996-04-03 AT AT96200875T patent/ATE181485T1/de active
- 1996-04-03 DK DK96200875T patent/DK0736256T3/da active
- 1996-04-03 ES ES96200875T patent/ES2138284T3/es not_active Expired - Lifetime
- 1996-04-03 DE DE69602985T patent/DE69602985T2/de not_active Expired - Fee Related
- 1996-04-08 JP JP8085601A patent/JPH08283163A/ja active Pending
-
1999
- 1999-08-26 GR GR990402169T patent/GR3031086T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0736256A1 (de) | 1996-10-09 |
| US6306828B1 (en) | 2001-10-23 |
| EP0736256B1 (de) | 1999-06-23 |
| JPH08283163A (ja) | 1996-10-29 |
| AU5045696A (en) | 1996-10-17 |
| DK0736256T3 (da) | 1999-11-22 |
| CA2173270A1 (en) | 1996-10-07 |
| AU707531B2 (en) | 1999-07-15 |
| GR3031086T3 (en) | 1999-12-31 |
| DE69602985D1 (de) | 1999-07-29 |
| ES2138284T3 (es) | 2000-01-01 |
| DE69602985T2 (de) | 2000-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3967388B2 (ja) | 改良された口当たり性を有する経口的に摂取可能な栄養組成物 | |
| DE69602985D1 (de) | Mit Enantiomeren angereichertes, energiereiches Nahrungsmittel | |
| US3849554A (en) | Reduction of blood serum cholesterol | |
| TW200744463A (en) | Nutritional supplement containing long-chain polyunsaturated fatty acids | |
| DK0515460T3 (da) | Docosahexaensyre, fremgangsmåder til fremstilling deraf og forbindelser indeholdende samme | |
| CA2244608A1 (en) | Nutritional product with high fat, low carbohydrate and amino acid imbalance | |
| CA2405822A1 (en) | Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof | |
| FR2714574B1 (fr) | Nouveaux suppléments alimentaires pour la nutrition des très jeunes enfants. | |
| GR3032548T3 (en) | Nutrition for persons undergoing radiation therapy and/or chemotherapy. | |
| ATE148920T1 (de) | Verfahren zur enzymatischen herstellung von alpha-sialylierten oligosaccharid-glykosiden | |
| DK0754001T3 (da) | Næringsmiddelprodukt til behandling af colitis ulcerosa og anvendelse deraf | |
| AU652785B2 (en) | Nutrition | |
| NO984859D0 (no) | Additiv for anvendelse i et energitilskudd, anvendelse av et proteinhydrolysat for fremstilling av energitilskudd inneholdende et slikt additiv | |
| AU2002305011A1 (en) | Enzyme treated maple syrup, shelf stable, pure maple based products, and blended products | |
| CA2100774A1 (en) | Feed additive and method | |
| DE69205562D1 (de) | Dicarbonsäure-derivate von 6-12 kohlenstoffatomen sowie anwendung dieser derivate sowie der freien dicarbonsäuren zur herstellung von arzneimitteln zur enteralen und parenteralen ernährung. | |
| Bitutskaya et al. | Functional food compositions using spirulina for the production of health jelly | |
| And et al. | Essential fatty acids in human colostrum | |
| Yeh | Specific nutrient: role of arginine in sepsis | |
| Rao et al. | Nutritional inadequacy of lieber-decarli alcohol diet | |
| LAWAN et al. | Amount of n-3 fatty acid in freshwater fish found in Northeast Thailand | |
| CAI et al. | The effects and the mechanisms of exogenous fatty acids on colorectal cancer cells | |
| Winitz | Reduction of blood serum cholesterol | |
| JPS6474995A (en) | Production of prostaglandin | |
| Sandanov et al. | Characteristics of central metabolism in coryneform bacteria |